The treatment measures of secondary myelofibrosis include general treatment, drug treatment, surgical treatment, etc. The treatment of this disease needs to be combined with a variety of measures according to the condition, and there is no absolute best way of treatment.
Secondary myelofibrosis mainly refers to the proliferation of bone marrow fibrous tissue on the basis of a clear primary disease, most of which are combined with hematopoietic abnormalities, and is commonly seen in leukemia, lymphoma, multiple myeloma, autoimmune diseases, chemical drugs, radiation therapy and so on.
1. When treating this disease, on the one hand, it is necessary to treat the primary disease, for example, leukemia can use vincristine and other drugs for chemotherapy.
2. On the basis of treating the primary disease, general treatment measures such as transfusion of red blood cells to improve anemia can be taken; androgens, erythropoietin and other drugs can be taken to improve anemia, and rucotinib and other drugs to improve fibrosis and so on. Meanwhile, for those who are combined with severe malignant disease and splenomegaly that cannot be improved by drugs, surgical treatment measures such as splenectomy can be taken to intervene.
However, which treatment is the best, need to be based on the condition of the comprehensive judgment, choose several treatment measures to achieve the best results, there is no single absolute best treatment measures. If secondary myelofibrosis occurs, it is recommended to go to the hospital in time; the above drugs need to be used under the guidance of clinicians.